Adult T-cell leukemia/lymphoma Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

10 events

Jun 2026Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

Children's Oncology Group — PHASE2, PHASE3

TrialNOT YET RECRUITING

Jun 2026U69-CART-Cells For R/R T-ALL

The First Affiliated Hospital of Soochow University — PHASE1

TrialRECRUITING

Jun 2026A Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic Leukemia/Lymphoma Who Are Intolerant to Intensive Chemotherapy

Zhujiang Hospital — EARLY_PHASE1

TrialNOT YET RECRUITING

Mar 2026Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma

National Cancer Institute (NCI) — PHASE1

TrialRECRUITING

Dec 2025Daratumumab for T Cell ALL With MRD-positive After Standard Chemotherapy

Institute of Hematology & Blood Diseases Hospital, China — PHASE2

TrialNOT YET RECRUITING

Sep 2025Clinical Study of LV009 Injection for the Treatment of Relapsed/Refractory CD19-Positive Hematologic and Lymphoid Malignancies

PersonGen BioTherapeutics (Suzhou) Co., Ltd. — EARLY_PHASE1

TrialRECRUITING

Sep 2025Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients

The First Affiliated Hospital of Soochow University — PHASE2

TrialRECRUITING

Jun 2025uCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies

Institute of Hematology & Blood Diseases Hospital, China — PHASE1

TrialRECRUITING

Jun 2025SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies

Institute of Hematology & Blood Diseases Hospital, China — PHASE1, PHASE2

TrialRECRUITING

Jun 2025A Phase I Dose Finding Study of MB-CART2219.1

University Hospital Tuebingen — PHASE1

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Adult T-cell leukemia/lymphoma.
Check the disease page for updates →

Clinical Trial Landscape

16 active trials

4Phase 2

7Phase 1

3Unknown

2PHASE1, PHASE2

16Total recruiting

Search clinical trials for Adult T-cell leukemia/lymphoma →

Recent News & Research

No recent news articles indexed yet for Adult T-cell leukemia/lymphoma.
Search PubMed for Adult T-cell leukemia/lymphoma →

Browse all Adult T-cell leukemia/lymphoma news →

Specialist Network

Top 6 by expertise

Hagop Kantarjian, MD, MD

M.D. Anderson Cancer Center

📍 HOUSTON, TX

Score 397 trials

He Huang, MD

Zhejiang University

📍 Hanzhou, Zhejiang

Score 3911 trials

Global Clinical Leader

Daiichi Sankyo

Score 3644 trials4 pubs

Farhad Ravandi-Kashani, M.D

SWOG Cancer Research Network

📍 HOUSTON, TX

Score 257 trials2 pubs

Ambroise MARCAIS, MD

Assistance Publique-Hôpitaux Paris

Score 241 trial

Prof. Dr. Michael Schmitt

University Hospital Heidelberg, Department V

Score 231 trial

View all Adult T-cell leukemia/lymphoma specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰